Rapamycin formulations for oral administration

Details Rapamycin formulations for oral administration Rapamycin formulations for oral administration

1998-03-11

1999-11-23

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

424479, 424480, 424494, 424489, A61K 922

Patent

active

059895918

ABSTRACT:
This invention provides rapamycin solid dosage unit which comprises a core and a sugar overcoat, said sugar overcoat comprising rapamycin, one or more surface modifying agents, one or more sugars, and optionally one or more binders.

REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4753801 (1988-06-01), Oren et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5100899 (1992-03-01), Calne
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5516770 (1996-05-01), Waranis et al.
patent: 5530006 (1996-06-01), Waranis et al.
patent: 5536729 (1996-07-01), Waranis et al.
patent: 5559121 (1996-09-01), Harrison et al.
patent: 5616588 (1997-04-01), Waranis et al.
patent: 5691334 (1997-11-01), Doria et al.
patent: 5725883 (1998-03-01), Staniforth et al.

Affiliated with

Also associated with

Rating

Rapamycin formulations for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rapamycin formulations for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapamycin formulations for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1218500